Commentary on Hsiue et al: Cost savings and data limitations of new cancer drug studies Editorial

  

Author:	Bach, P. B.
Title:	Commentary on Hsiue et al: Cost savings and data limitations of new cancer drug studies
Keywords:	cancer chemotherapy; cancer survival; overall survival; drug efficacy; drug safety; risk benefit analysis; drug approval; note; united states; antineoplastic agent; smoking; food and drug administration; cost control; drug cost; clinical decision making; drug control; national health organization; cardiovascular mortality; human; priority journal
Journal Title:	Clinical Trials
Volume:	17
Issue:	2
ISSN:	1740-7745
Publisher:	Sage Publications
Date Published:	2020-04-01
Start Page:	126
End Page:	128
Language:	English
DOI:	10.1177/1740774520907668
PUBMED:	32070123
PROVIDER:	scopus
DOI/URL:	https://www.scopus.com/inward/record.uri?eid=2-s2.0-85081600973&doi=10.1177%2f1740774520907668&partnerID=40&md5=35b74e7df7e6777a3d3d50a16605d565
Notes:	Note -- Source: Scopus

https://synapse.mskcc.org/synapse/works/has_related_data_chk/166067